The market taxonomy of Microfluidics Services by type categorizes the value‑chain activities that generate revenue. Design & Prototyping services, encompassing CAD modeling, simulation, and rapid‑iteration molds, represent the front‑end of the value chain and capture roughly 35 % of total service spend, as clients prioritize bespoke channel architectures before scale‑up. Fabrication—including soft‑lithography, injection molding, and 3D‑printed substrates—accounts for about 30 % of the market, reflecting the material‑intensive nature of producing functional chips at pilot volumes. Testing & Validation services, such as fluidic performance assays, leak testing, and biocompatibility verification, contribute close to 20 %, driven by stringent regulatory requirements across pharma and diagnostics. Consulting & Integration activities, which guide clients through workflow optimization, regulatory strategy, and system integration, hold an estimated 10 % share, underscoring the need for expertise in translating microfluidic concepts into operational processes. Finally, Data Analytics & Software services, providing real‑time signal processing and cloud‑based analysis, occupy the remaining 5 %, a niche that is expanding as digital health platforms demand end‑to‑end data pipelines. Collectively, these type segments delineate how service providers allocate resources and shape the overall market size.